Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(3 sites)

United States

Glaukos Investigative Site, Grand Junction, Colorado

Glaukos Investigative Site, Oklahoma City, Oklahoma

Glaukos Clinical Site, El Paso, Texas